Total Payments
$498.13
2024 Payments
$92.69
Companies
11
Transactions
16
Medicare Patients
4,086
Medicare Billing
$701,125
Payment Breakdown by Category
Food & Beverage$423.57 (85.0%)
Education$74.56 (15.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $423.57 | 14 | 85.0% |
| Education | $74.56 | 2 | 15.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $103.17 | 3 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $101.70 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $88.10 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $59.72 | 3 | $0 (2024) |
| Horizon Therapeutics plc | $31.71 | 2 | $0 (2019) |
| Travere Therapeutics, Inc. | $27.51 | 1 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $24.61 | 1 | $0 (2024) |
| Relypsa, Inc. | $20.81 | 1 | $0 (2017) |
| Genentech USA, Inc. | $15.68 | 1 | $0 (2017) |
| bioMerieux | $13.62 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $92.69 | 4 | Travere Therapeutics, Inc. ($27.51) |
| 2023 | $57.87 | 2 | AstraZeneca Pharmaceuticals LP ($31.39) |
| 2022 | $239.75 | 3 | Aurinia Pharma U.S., Inc. ($101.70) |
| 2019 | $45.33 | 3 | Horizon Therapeutics plc ($31.71) |
| 2018 | $26.00 | 2 | Otsuka America Pharmaceutical, Inc. ($14.50) |
| 2017 | $36.49 | 2 | Relypsa, Inc. ($20.81) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.83 | General |
| 11/21/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $27.51 | General |
| 09/25/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 06/25/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: NEPHROLOGY | ||||||
| 10/04/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: NEPHROLOGY | ||||||
| 08/31/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Education | In-kind items and services | $49.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $101.70 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/30/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $88.10 | General |
| Category: Cardio-renal | ||||||
| 06/02/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: KRYSTEXXA | ||||||
| 05/16/2019 | bioMerieux | — | Food and Beverage | In-kind items and services | $13.62 | General |
| 02/09/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: KRYSTEXXA | ||||||
| 07/30/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEPHROLOGY | ||||||
| 05/07/2018 | Amgen Inc. | Parsabiv (Biological), Sensipar | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Nephrology | ||||||
| 08/15/2017 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: BioOncology/Immunology | ||||||
| 01/04/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 954 | 2,009 | $527,116 | $152,321 |
| 2022 | 11 | 982 | 1,876 | $485,248 | $137,380 |
| 2021 | 13 | 967 | 2,239 | $665,777 | $202,497 |
| 2020 | 14 | 1,183 | 2,465 | $813,162 | $208,926 |
Total Patients
4,086
Total Services
8,589
Medicare Billing
$701,125
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 308 | 668 | $155,644 | $34,524 | 22.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 20 | 130 | $123,500 | $33,627 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 217 | 536 | $85,224 | $31,349 | 36.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 150 | 293 | $66,218 | $25,679 | 38.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 91 | 94 | $42,112 | $11,915 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $19,200 | $5,109 | 26.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 32 | $10,272 | $3,090 | 30.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 18 | 64 | $9,600 | $2,150 | 22.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 17 | 62 | $7,130 | $2,000 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 32 | $4,736 | $1,767 | 37.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 33 | $2,580 | $936.72 | 36.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 12 | 15 | $900.00 | $173.42 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 323 | 660 | $153,780 | $37,480 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 243 | 581 | $92,379 | $30,205 | 32.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 18 | 87 | $82,650 | $22,836 | 27.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 143 | 260 | $58,760 | $19,154 | 32.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 89 | 93 | $41,664 | $13,090 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $18,816 | $5,637 | 30.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 29 | 31 | $9,951 | $3,114 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 41 | $6,068 | $2,345 | 38.6% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 18 | 36 | $13,140 | $2,266 | 17.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 15 | 16 | $5,840 | $820.89 | 14.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 22 | $2,200 | $431.10 | 19.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 280 | 603 | $140,499 | $53,235 | 37.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 34 | 178 | $169,100 | $48,183 | 28.5% |
About Dr. Ralph Atkinson, M.D
Dr. Ralph Atkinson, M.D is a Nephrology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083606248.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Atkinson, M.D has received a total of $498.13 in payments from pharmaceutical and medical device companies, with $92.69 received in 2024. These payments were reported across 16 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($423.57).
As a Medicare-enrolled provider, Atkinson has provided services to 4,086 Medicare beneficiaries, totaling 8,589 services with total Medicare billing of $701,125. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Nashville, TN
- Active Since 08/15/2005
- Last Updated 02/05/2026
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1083606248
Products in Payments
- LUPKYNIS (Drug) $101.70
- Kerendia (Drug) $88.10
- JYNARQUE (Drug) $59.72
- LOKELMA (Drug) $49.95
- KRYSTEXXA (Biological) $31.71
- FARXIGA (Drug) $31.39
- Vafseo (Drug) $24.61
- Veltassa (Drug) $20.81
- Rituxan (Biological) $15.68
- Parsabiv (Biological) $11.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Nashville
Dr. Jamie Dwyer, M.d, M.D
Nephrology — Payments: $549,974
Nephrology $549,974
Talat Ikizler, Md, MD
Nephrology — Payments: $240,153
Nephrology $240,153
Julia Lewis, Md, MD
Nephrology — Payments: $126,571
Nephrology $126,571
Dr. Volker Haase, M.d, M.D
Nephrology — Payments: $125,972
Nephrology $125,972
Alfred George, Md, MD
Nephrology — Payments: $51,836
Nephrology $51,836
Dr. Thomas Golper, Md, MD
Nephrology — Payments: $33,757
Nephrology $33,757